BRCA1/2 mutations appear embryo-lethal unless rescued by low (CGG n<26) FMR1 sub-genotypes: explanation for the "BRCA paradox"?

BRCA1/2 mutations appear embryo-lethal unless rescued by low (CGG n<26) FMR1 sub-genotypes: explanation for the "BRCA paradox"?

BRCA1/2 mutations and recently described constitutional FMR1 genotypes have, independently, been associated with prematurely diminished ovarian reserve. Whether they interrelate in distribution, and whether observed effects of BRCA1/2 and FMR1 on ovaries are independent of each other, is unknown. In...

Full description

Bibliographic Details
Main Authors:	Andrea Weghofer, Muy-Kheng Tea, David H Barad, Ann Kim, Christian F Singer, Klaus Wagner, Norbert Gleicher
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22984553/pdf/?tool=EBI

Similar Items

Absence of BRCA/FMR1 correlations in women with ovarian cancers.
by: Norbert Gleicher, et al.
Published: (2014-01-01)

Association of skewed X-chromosome inactivation with FMR1 CGG repeat length and anti-Mullerian hormone levels: a cohort study
by: David H. Barad, et al.
Published: (2017-04-01)

How the FMR1 gene became relevant to female fertility and reproductive medicine
by: Norbert eGleicher, et al.
Published: (2014-08-01)

The impact in older women of ovarian FMR1 genotypes and sub-genotypes on ovarian reserve.
by: Norbert Gleicher, et al.
Published: (2012-01-01)

Association of FMR1 genotypes with in vitro fertilization (IVF) outcomes based on ethnicity/race.
by: Norbert Gleicher, et al.
Published: (2011-01-01)

Low-Normal FMR1 CGG Repeat Length: Phenotypic Associations
by: Marsha eMailick, et al.
Published: (2014-09-01)

FMR1 genotype with autoimmunity-associated polycystic ovary-like phenotype and decreased pregnancy chance.
by: Norbert Gleicher, et al.
Published: (2010-12-01)

Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the <it>FMR1</it> gene
by: Gleicher Norbert, et al.
Published: (2012-09-01)

Studies of the CGG Trinucleotide Repeats in FMR-1 Gene of Fragile X Syndrome
by: Wang, Chyong-Huey, et al.

FMR1 Low Zone CGG Repeats: Phenotypic Associations in the Context of Parenting Stress
by: Marsha R. Mailick, et al.
Published: (2020-05-01)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.
by: Melissa S Cline, et al.
Published: (2018-12-01)

BRCA1- und BRCA2-Mutationsträger
by: Mohr, Christina
Published: (2014)

Association between IQ and FMR1 protein (FMRP) across the spectrum of CGG repeat expansions.
by: Kyoungmi Kim, et al.
Published: (2019-01-01)

Transcription-associated R-loop formation across the human FMR1 CGG-repeat region.
by: Erick W Loomis, et al.
Published: (2014-04-01)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
by: Kara N. Maxwell, et al.
Published: (2017-08-01)

Molecular Trajectory of BRCA1 and BRCA2 Mutations
by: Yuichiro Hatano, et al.
Published: (2020-03-01)

Epistatic relationships in the BRCA1-BRCA2 pathway.
by: Ralph Scully
Published: (2011-07-01)

BRCA1, BRCA2 and primary ovarian insufficiency
by: Zhang Yinuo
Published: (2020-01-01)

The significance of FMR1 CGG repeats in Chinese women with premature ovarian insufficiency and diminished ovarian reserve
by: Ruiyi Tang, et al.
Published: (2020-08-01)

Closely linked cis-acting modifier of expansion of the CGG repeat in high risk FMR1 haplotypes
by: Ennis, S., et al.
Published: (2007)

The prevalence of CGG repeat expansion mutation in FMR1 gene in the northern Chinese women of reproductive age
by: Yinan Ma, et al.
Published: (2019-05-01)

First International Workshop on the Function of Brca1 and Brca2
by: Mary-Jean Mitchell Green Cancer Foundation
Published: (1998-01-01)

Risk modelling in BRCA1 and BRCA2 mutation carriers
by: Mavaddat, Nasim
Published: (2012)

Cancer risks in BRCA1 and BRCA2 mutation carriers
by: Thompson, Deborah Jane
Published: (2002)

BRCA1 and BRCA2 Tumor Suppressor Function in Meiosis
by: Qianyan Li, et al.
Published: (2021-04-01)

FMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserve
by: Julia Rehnitz, et al.
Published: (2018-07-01)

Association between family history, mutation locations, and prevalence of BRCA1 or 2 mutations in ovarian cancer patients
by: Christian F. Singer, et al.
Published: (2019-04-01)

<it>BRCA1 </it>testing
by: Górski Bohdan, et al.
Published: (2008-06-01)

Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome.
by: Nina Xie, et al.
Published: (2016-01-01)

LOSS OF HETEROZYGOSITY IN THE BRCA1 AND BRCA2 LOCUS IN BREAST CANCER
by: M. M. Tsyganov, et al.
Published: (2020-07-01)

Occurrence of BRCA1 and BRCA2 mutation in pancreatic cancer patients
by: A. A. Kashintsev, et al.
Published: (2016-02-01)

BRCA1 and BRCA2 and Inherited Predisposition to Breast and Ovarian Cancers
by: Patricia N. Tonin
Published: (2002-12-01)

Diagnostic Screening Workflow for Mutations in the BRCA1 and BRCA2 Genes
by: Stella Lai, et al.
Published: (2015-02-01)

Prostate screening uptake in Australian <it>BRCA1 </it>and <it>BRCA2 </it>carriers
by: McKinley Joanne M, et al.
Published: (2007-09-01)

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
by: Ellen Warner
Published: (2018-11-01)

BRCA1 and BRCA2: Lack of Certainty and Its Clinical Implications
by: Samuel J Haryono
Published: (2017-02-01)

BRCA1 and BRCA2 Germline Mutations in Asian and European Populations
by: Ute Hamann
Published: (2017-02-01)

Diagnostic Screening Workflow for Mutations in the BRCA1 and BRCA2 Genes
by: Stella Lai, et al.
Published: (2015-01-01)

Genomic rearrangements in BRCA1 and BRCA2: a literature review
by: Ingrid Petroni Ewald, et al.
Published: (2009-01-01)

Risk assessment for hereditary breast cancer: BRCA1 and BRCA2
by: Kendra-Ann I. Seenandan-Sookdeo, et al.
Published: (2010-07-01)